EBV Early Antigen

Product Overview

Recombinant Epstein Barr Virus Early Antigen

Specificity

Immunoreactive with sera of EBV-infected individuals.

Nature

Recombinant

Tag/Conjugate

Unconjugated

Purity

> 95% pure by 10% PAGE (Coomassie staining)

Format

Liquid

Buffer

50 mM Tris-HCl, 10mM glutation, 60 mM NaCl, 0.5% sarcosyl, 50% glycerol

Preservative

None

Storage

2-8°C short term, -20°C long term

Introduction

The Epstein–Barrvirus (EBV), also called human herpesvirus5(HHV-4), is a virus of theherpes family, which includes herpes simplex virus 1 and 2, and is one of themost common viruses in humans. It is best known as the cause of infectiousmononucleosis. It is also associated with particular forms of cancer, particularlyHodgkin"s lymphoma, Burkitt"s lymphoma, nasopharyngeal carcinoma, and centralnervous system lymphomas associated with HIV. Finally, there is evidence thatinfection with the virus is associated with a higher risk of certainautoimmune diseases, especially dermatomyositis, systemic lupuserythematosus, rheumatoid arthritis and multiplesclerosis.

Keywords

BMRF1; Early antigen; EBV EA; EBV early antigen; Epstein Barr virus EA; Epstein Barr virus early antigen; Epstein Barr virus early antigen; HHV4 EA; HHV4 early antigen; HHV4 early antigen; Human herpesvirus 4 EA; Humanherpesvirus 4 early antigen diffuse E